Application of Luteolin in Neoplasms and Nonneoplastic Diseases

Application of Luteolin in Neoplasms and Nonneoplastic Diseases

Researchers are amazed at the multitude of biological effects of 3′,4′,5,7-tetrahydroxyflavone, more commonly known as luteolin, as it simultaneously has antioxidant and pro-oxidant, as well as antimicrobial, anti-inflammatory, and cancer-preventive, properties. The anticancer properties of luteolin...

Full description

Bibliographic Details
Main Authors:	Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, Natalia Szymańska, Jakub Stecko, Jakub Sleziak, Julita Kulbacka, Dagmara Baczyńska
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	International Journal of Molecular Sciences
Subjects:	luteolin flavonoids carcinogenesis COVID-19 diabetes mellitus skin diseases
Online Access:	https://www.mdpi.com/1422-0067/24/21/15995

Similar Items

Luteolin 7-Sulfate Attenuates Melanin Synthesis through Inhibition of CREB- and MITF-Mediated Tyrosinase Expression
by: Seok Won Lee, et al.
Published: (2019-04-01)

Comparative Study of the Pharmacological Properties of Luteolin and Its 7,3′-Disulfate
by: Emma P. Kozlovskaya, et al.
Published: (2022-06-01)

Physicochemical Properties and Antioxidant Activities of Luteolin-Phospholipid Complex
by: Zhengxiang Ning, et al.
Published: (2009-09-01)

Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside
by: Sabrina Caporali, et al.
Published: (2022-03-01)

Therapeutic Potential of Luteolin on Cancer
by: Melisa Çetinkaya, et al.
Published: (2023-02-01)

Immunopharmacological Activities of Luteolin in Chronic Diseases
by: Lei Huang, et al.
Published: (2023-01-01)

Influence of Stabilizer on the Development of Luteolin Nanosuspension for Cutaneous Delivery: An In Vitro and In Vivo Evaluation
by: Mohammed Elmowafy, et al.
Published: (2021-10-01)

Luteolin and quercetin affect aphid feeding behavior
by: S. Goławska, et al.
Published: (2024-01-01)

The hypolipidemic mechanism of chrysanthemum flavonoids and its main components, luteolin and luteoloside, based on the gene expression profile
by: Jihan Sun, et al.
Published: (2022-09-01)

Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats
by: Giovanna Casili, et al.
Published: (2020-10-01)

Evaluation of Diabetes Effects of Selenium Nanoparticles Synthesized from a Mixture of Luteolin and Diosmin on Streptozotocin-Induced Type 2 Diabetes in Mice
by: Rosa Martha Pérez Gutiérrez, et al.
Published: (2022-09-01)

Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
by: Young-Hyun Go, et al.
Published: (2020-10-01)

Harnessing Luteolin's therapeutic potential in human disorders: Medicinal significance, biological, clinical properties and analytical aspects
by: Abhishek Singh, et al.
Published: (2024-03-01)

Hypolipidemic Effects and Preliminary Mechanism of Chrysanthemum Flavonoids, Its Main Components Luteolin and Luteoloside in Hyperlipidemia Rats
by: Jihan Sun, et al.
Published: (2021-08-01)

New Insights on the Raman and SERS Spectra of Luteolin under Different Excitation Conditions: Experiments and DFT Calculations
by: Marilena Ricci, et al.
Published: (2023-02-01)

Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside
by: Alessandro De Stefano, et al.
Published: (2021-01-01)

Effects of Luteolin on Biofilm of <i>Trueperella pyogenes</i> and Its Therapeutic Effect on Rat Endometritis
by: Luyao Zhang, et al.
Published: (2022-11-01)

Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites
by: Orsolya Balázs, et al.
Published: (2023-11-01)

Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties
by: De-Yang Sun, et al.
Published: (2019-12-01)

Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review
by: Nandakumar Muruganathan, et al.
Published: (2022-11-01)

The Mechanism of a Retro-Diels–Alder Fragmentation of Luteolin: Theoretical Studies Supported by Electrospray Ionization Tandem Mass Spectrometry Results
by: Magdalena Śliwka-Kaszyńska, et al.
Published: (2022-02-01)

Revisiting luteolin: An updated review on its anticancer potential
by: Abdur Rauf, et al.
Published: (2024-03-01)

Determination of luteolin from extracts of Helicteres hirsuta by HPLC
by: Le Trung Hieu, et al.
Published: (2019-07-01)

Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin
by: Peng, Minhua, et al.
Published: (2017)

In vitro wound healing activity of luteolin
by: Z. Bayrami, et al.
Published: (2017-11-01)

Role of Luteolin-Induced Apoptosis and Autophagy in Human Glioblastoma Cell Lines
by: Hye-Sung Lee, et al.
Published: (2021-08-01)

Molecular Basis for Luteolin as a Natural TatD DNase Inhibitor in <i>Trueperella pyogenes</i>
by: Zehui Zhang, et al.
Published: (2022-07-01)

The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents
by: Roohi Mohi-ud-din, et al.
Published: (2022-04-01)

Antiviral Activity of Luteolin against Pseudorabies Virus In Vitro and In Vivo
by: Xiaoyu Men, et al.
Published: (2023-02-01)

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01)

Identification of luteolin 7-O-β-D-glucuronide from Cirsium japonicum and its anti-inflammatory mechanism
by: Qin Ma, et al.
Published: (2018-07-01)

Self-Emulsifying Phospholipid Preconcentrates for the Enhanced Photoprotection of Luteolin
by: Yun-Shan Hsieh, et al.
Published: (2022-09-01)

Luteolin 4′-Neohesperidoside Inhibits Clinically Isolated Resistant Bacteria In Vitro and In Vivo
by: Riham A. El-Shiekh, et al.
Published: (2023-03-01)

Physiological and histological effects of apigenin and luteolin on Cytarabine injected rats
by: Ghada A. Taqa, et al.
Published: (2024-01-01)

Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
by: Yasir Hasan Siddique, et al.
Published: (2018-11-01)

A20, as a downstream factor of Nrf2, is involved in the anti-neuroinflammatory and antidepressant-like effects of luteolin
by: Zhipeng Li, et al.
Published: (2022-12-01)

Luteolin-Loaded Nanoparticles for the Treatment of Melanoma
by: Fu QT, et al.
Published: (2023-04-01)

HPLC Method Optimization for Simultaneous Determination of Quercetin, Luteolin, Sinensetin, and Stigmasterol in Herbal Medicines
by: Asih Imulda Hari Purwani, et al.
Published: (2022-04-01)

Phytochemical screening and evaluation of antioxidant activities of Dracocephalum kotschyi and determination of its luteolin content
by: Mansureh Kamali, et al.
Published: (2016-06-01)

Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak
by: Mohammad Mahfuz Ali Khan Shawan, et al.
Published: (2021-01-01)